April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H. Neal Award winner in the Best Technical Content category for its team coverage of the topic of gadolinium.
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
-
-
ITN Contributing Editor Greg Freiherr speaks with Guerbet Chief Commercial Officer David Hale about the latest advanced digital solutions the company was showing at RSNA...
-
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help medical imaging, explains how AI might be used to reduce the amount of gadolinium contrast needed for magnetic resonance imaging (MRI) exams.
-
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in the body after magnetic resonance imaging (MRI) exams, according to a new study. The study was presented at the 2018 annual meeting of the Radiological Society of North America (...
-
Lawrence Tanenbaum, M.D., FACR, vice president and director of advanced imaging at RadNet, discusses the latest research on the effects of gadolinium contrast retention following magnetic resonance imaging (MRI) exams, and how facilities can best manage its use.
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H. Neal Award winner in the Best...
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.
Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
GU12171120
Sponsored Content | Case Study | Contrast Media Injectors | April 02, 2019
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of...
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with...
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help...
News | Interventional Radiology | December 12, 2018
December 12, 2018 — Guerbet LLC USA highlighted new and next-level product offerings and partnerships in...
News | Contrast Media | November 30, 2018
November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration...
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.
News | Contrast Media | November 27, 2018
November 27, 2018 — Researchers are using...
News | Clinical Decision Support | November 21, 2018
November 21, 2018 — Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM...
News | Contrast Media | November 14, 2018
November 14, 2018 — Voyageur Minerals Ltd. signed a joint venture agreement with Chief Medical Supply Ltd (CM) of...
News | Angiography | September 25, 2018
September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys...
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.
News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore...
Researchers in the laboratory ‘Biomedical Nanomaterials’ of NUST MISIS. Image courtesy of PR Newsfoto/NUST MISIS.
News | Oncology Diagnostics | August 24, 2018
August 24, 2018 — A European research group has developed a system that allows doctors to both improve the accuracy...
Scientists at Rice's Laboratory for Nanophotonics added iron chelates (blue) and fluorescent dye (red) to multi-layered gold nanomatryoshkas to create particles that can be used for disease therapy and diagnostics. The "theranostic" nanoparticles have a core of gold (left) that is covered by silica containing the diagnostic iron and dye, which is covered by an outer shell of gold. The particles are about 20 times smaller than a red blood cell, and by varying the thickness of the layers, LANP scientists can tune the nanomatryoshkas to convert light into cancer-killing heat. (Image courtesy of Luke Henderson/Rice University)
News | Contrast Media | August 22, 2018
August 22, 2018 — Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to...
News | Radiation Dose Management | August 14, 2018
August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of...
Videos | Contrast Media | August 03, 2018
Lawrence Tanenbaum, M.D., FACR, vice president and director of advanced imaging at RadNet, discusses the latest...
